Keytruda: FDA Approves Melanoma Drug That Uses Immune System To Fight Cancer

The U.S. Food and Drug Administration has approved Keytruda (pembrolizumab), a new immunotherapy drug to treat advanced melanoma after it was tested on more than 600 patients who had melanoma that had spread throughout their bodies.

Related Keywords

Australia ,Judith Gasson ,Antoni Ribas ,David Geffen School Of Medicine ,Jonsson Comprehensive Cancer Center ,Drug Administration ,Jonsson Cancer Center ,David Geffen School ,Comprehensive Cancer ,Clinical Research ,